General Manager Chen Zheng: Don’t forget the original intention is to make a new drug for the Chinese!

Financier/Provided

Beijing time 2012/January issue MAG magazine cabinet

Text: Liang Bixia

It has been 16 years since I returned to Taiwan, and Nina Gong, chairman of Hong Kong Chinachem Group (commonly known as Britney in Hong Kong), said: Why are you developing foreigners’ drugs abroad, come back! Make some good medicine for Chinese people. I thought: the biotech company I want to make must be backed by government funds, and must have the business acumen of Taiwanese and Hong Kong people! The general manager of Jianya Biotechnology Co., Ltd. said excitedly that the dream of starting a business was ……! General Manager Chen Zheng said with a smile: As soon as my wife knew that the listing price was only 13 yuan, she almost turned her face with me! Hehe, in the past 16 years, I have given up the American dream and returned to Taiwan to cultivate the acres of biotechnology, only to know that “it is one thing for products to leave the laboratory” and “it is another thing for products to be sold into the pharmaceutical system”.

Image

General Manager of Jianya Chen Zheng

It has been 16 years since the National Development Fund invested in our company, and we are the first new drug development company invested by the National Development Fund. General Manager Chen Zheng said that the company was the first person to thank when it was listed. He propped his hands on the table, looking excited. He breathed a sigh of relief and said: Overall, there is more happiness than pain, because we have a group of about 20 R&D team and have been working hard for more than 10 years! International Jingding, Youhua and foreign pharmaceutical companies… There are many senior executives who are Jianya’s people! After deducting about $0.5 per share per share, we still have a lot of “spillover effects” (referring to the economic benefits of earnings per share, as well as contributions to society such as talent training, patented inventions, and improving the level of drug use).

Only new drugs can have a trillion yuan industry!

Taiwan’s biotechnology industry is divided into new drugs, generic drugs, medical cosmetology, testing reagents… Wait, if the government says that the trillion dollar industry is true, then how can there be a trillion yuan industry without new drug research and development?! Jianya is still a new drug research and development company! Chen Zheng has a deep helplessness about the underwriter’s low price-to-earnings ratio, and said to the underwriting price of 13 yuan: I sold my ancestral property cheaply. After participating in the legal conference with Jianya’s cooperative manufacturers for many years, when they heard the underwriting price of 13 yuan, everyone raised their hands and said that they wanted to recognize it! However, the underwriting volume is 10,000 copies, which is not enough for distribution, and some people want to recognize 500 copies, and in the end they only recognize less than 1 discount. Chen Zheng was scolded by the strategic partner manufacturer, just a week before the listing, Chen Zheng called one by one to apologize, he described: I knelt until my knees were bleeding! There was a miserable smile on his face.

Britney Gong Nina has always been concerned about the development of cancer drugs

When Chen Zheng talked about Nina Gong, chairman of Chinachem Group, the richest man in Hong Kong, he said bluntly: She is a great woman! She is very far-sighted, Britney donated money to senior officers of the Communist Party of China, the purpose is to go to the United States Harbin University to study management, the main reason is to manage China’s guns, China will no longer have military turmoil, this is the original intention to save 1.4 billion people from dire straits. Nina Gong brought Chen Zheng back from the United States, but unfortunately she died of cancer in 2007, not waiting for her to plant a seed of new cancer drug research and development 16 years ago, but with more and more outstanding talents into research and development, the road traveled by predecessors, future generations continue to struggle. On the day of the listing of Jianya, Chen Shu, chairman of the counter buying center, inscribed a couplet of “Healthy and smooth and great wishes, Asia-Pacific is a majestic sage”! Chen Zheng said: The listing has just begun, but it is always gratifying to have a good start.